PeptidePedia The community reference

Trial data comparison: difference between revisions

Diff·revision 19 → 20·15:56, 21 Aug 2025

Difference between revision 19 and revision 20 of Trial data comparison. 3 lines changed; the page grew by 235 bytes.

Revision 19 — 15:27, 8 Aug 2025
MOTSc_Mira (talk)
expand §Why the estimand matters
5,803 bytes +182
Revision 20 — 15:56, 21 Aug 2025
ConsensusConal (talk)
expand §Why the estimand matters
6,038 bytes +235
54'''Background therapy.''' Trials differ in whether metformin, insulin or a sulfonylurea was permitted, which affects both glycaemic and weight endpoints and the hypoglycaemia rate.54'''Background therapy.''' Trials differ in whether metformin, insulin or a sulfonylurea was permitted, which affects both glycaemic and weight endpoints and the hypoglycaemia rate.
5555
+56'''Comparator.''' Placebo-controlled and active-controlled trials answer different questions. A placebo-adjusted difference and an absolute change are frequently confused; see [[Placebo-adjusted effect]].
+57
56== References ==58== References ==
57{{reflist}}59{{reflist}}
68* [[Intention-to-treat analysis]]70* [[Intention-to-treat analysis]]
69* [[Placebo-adjusted effect]]71* [[Placebo-adjusted effect]]
+72* [[Number needed to treat]]
7073
71{{DEFAULTSORT:Trial data comparison}}74{{DEFAULTSORT:Trial data comparison}}